Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Lx2761
2. N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-(3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl)phenyl)butanamide
1. Lx2761
2. 1610954-97-6
3. Lx-2761
4. Chembl4074614
5. Schembl15741132
6. Bdbm176714
7. Ex-a2828
8. Ac-31562
9. Hy-101122
10. Cs-0020883
11. A903438
12. N-[2-(dimethylamino)ethyl]-2-methyl-2-[4-[4-[[2-methyl-5-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]phenyl]methyl]phenyl]butanoylamino]propanamide
13. N-[2-(dimethylamino)ethyl]-2-methyl-2-[4-[4-[[2-methyl-5-[(2s,3r,4r,5s,6r)-6-methylsulfanyl-3,4,5-tris(oxidanyl)oxan-2-yl]phenyl]methyl]phenyl]butanoylamino]propanamide
14. Us9688710, 136 N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl)phenyl)butanamide
| Molecular Weight | 601.8 g/mol |
|---|---|
| Molecular Formula | C32H47N3O6S |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 13 |
| Exact Mass | 601.31855740 g/mol |
| Monoisotopic Mass | 601.31855740 g/mol |
| Topological Polar Surface Area | 157 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 852 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
33
PharmaCompass offers a list of LX-2761 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right LX-2761 manufacturer or LX-2761 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LX-2761 manufacturer or LX-2761 supplier.
PharmaCompass also assists you with knowing the LX-2761 API Price utilized in the formulation of products. LX-2761 API Price is not always fixed or binding as the LX-2761 Price is obtained through a variety of data sources. The LX-2761 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LX-2761 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LX-2761, including repackagers and relabelers. The FDA regulates LX-2761 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LX-2761 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LX-2761 supplier is an individual or a company that provides LX-2761 active pharmaceutical ingredient (API) or LX-2761 finished formulations upon request. The LX-2761 suppliers may include LX-2761 API manufacturers, exporters, distributors and traders.
LX-2761 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LX-2761 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LX-2761 GMP manufacturer or LX-2761 GMP API supplier for your needs.
A LX-2761 CoA (Certificate of Analysis) is a formal document that attests to LX-2761's compliance with LX-2761 specifications and serves as a tool for batch-level quality control.
LX-2761 CoA mostly includes findings from lab analyses of a specific batch. For each LX-2761 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LX-2761 may be tested according to a variety of international standards, such as European Pharmacopoeia (LX-2761 EP), LX-2761 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LX-2761 USP).
